Quantum Physics and Cancer

Article

What can science tell us about life, death and disease?

Most people don't understand quantum mechanics. Richard Feynman was a physicist who won a Nobel Prize for his work in developing an understanding of quantum mechanics, who famously said, "If you think you understand quantum mechanics, you don't understand quantum mechanics." Those seemingly simple words are, in fact, a testament as to how unimaginable the world — or at least the parts we don't see – really is. Quantum physics, simply put, is the study of very small things in very small places.

There is much debate and a good deal of excitement in the world of medical science that cancer may be cured at a quantum level one day. As an example, Toshio Hirano, chief of the National Institutes for Quantum and Radiological Science and Technology in Japan aims to bring quantum technology to the forefront of contributions to human society, by creating a quantum scalpel to attack tumors without cutting skin, using heavy ions fired through the body. In contrast to radiotherapy's gamma and X-rays, charged particles, such as protons, release most of their energy upon reaching the target tumor. This reduces non-targeted damage and harmful side-effects.

After my wife died of cancer at the age of 47, I spent some time attempting to reorganize my life while searching for meaning in things and places and events and people that no longer had the connection of "us." I was on my own. I wanted to understand how such seemingly "unkind" things can occur in our lives, like a loved one being whisked away in the blink of an eye and removed from our experience like so many other memories that we carry.

I always knew that if I had not chosen to become a professional magician as my life's work that I would have become a scientist. Science has allowed us to experience what I can only describe as real magic in the world around us. The exquisite rhythm of the natural world; the existence of stars and galaxies and black holes; the remarkable complexity of the human immune system; and even the way cancer drives a path into our bodies — all of this is made graspable by science. And so, I turned to science, not to answer questions about why we live and die, but to instill in me a sense of wonder and amazement over the very fact that we are here at all. I make no religious inferences here. I'm not qualified to do so. I speak only from my own observations about how my life is enhanced by what I like to call our "Astonishmentality."

After my wife's death, I had a good deal of time on my hands, and I purchased every book that one of my hero's had written. Carl Sagan, the astronomer and popularizer of all things scientific, had lots of questions about how we live, how we perceive the world around us and how we interpret what we think we see. I found great solace in his wisdom and discovered a good deal of comfort in seeing — or at least sensing – that there is so much that we cannot know. All of these unanswered questions about life and death gave me a sense that my wife's death was very much more about things I could not understand than it was about how I felt about those things. I feel that way about my own cancer diagnosis, too.

I have in innate sense that life, just as it is, with all of the good and the bad and even the cancer that takes lives away, possibly even my own, is somehow perfection beyond what we can imagine. Science has given me hope and optimism and a belief in the flawlessness of this cycle we all experience: the act of existing for a relatively short time (30,000 days on average) and then being rearranged molecule by molecule into quantum form, the measure and magnificence of which even science can't begin to explain.

www.BreastCancerSpeaker.com

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content